Search clinical trials for: docetaxel oxaliplatin

Total 3930 results

AmpliMed Corporation

Completed

Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

Breast Cancer | Prostate Cancer | Non-small Cell Lung Cancer

United States
University College London Hospitals

Completed

Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer

Breast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2) | brca1 Mutation Carrier | brca2 Mutation Carrier

Australia, Israel, United Kingdom, Spain, Sweden, Portugal
Gustave Roussy, Cancer Campus, Grand Paris

Suspended

Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients

Prostate Cancer

France
Zhejiang University

Recruiting

Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases

Liver Metastases

China
Cancer Research UK

Completed

Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer

Colorectal Cancer

United Kingdom
Roswell Park Cancer Institute

Completed

Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum

Colorectal Cancer

United States
University of Chicago
National Cancer Institute (NCI)

Completed

Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer

Lung Cancer

United States
Shanghai Chest Hospital
The Affiliated Hospital of Qingdao University; Zhejiang University; Anhui Provincial...

Active, not recruiting

Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC) (AK104IIT018)

NSCLC Stage IV | NSCLC Stage IIIB | NSCLC Stage IIIC

China
Guangdong Provincial People's Hospital
First Affiliated Hospital, Sun Yat-Sen University; Henan Cancer Hospital; Dongguan... and other collaborators

Completed

DCb (Docetaxel/Carboplatin) Versus EC-D (Epirubicin/Cyclophosphamide Followed by Docetaxe) as Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

Triple-Negative Breast Cancer

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage

Gastric Cancer

China
National University Hospital, Singapore

Unknown

A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab

Rectal Cancer

Singapore
University Hospital, Montpellier
Federation Francophone de Cancerologie Digestive

Recruiting

Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma (GEMOXIA-02)

Cholangiocarcinoma Non-resectable | Non-metastatic

France
UNICANCER

Completed

Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer

Colorectal Cancer

France
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Center, Korea

Completed

A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer (TIROX2)

Stomach Neoplasms

Korea, Republic of
National Cancer Center, Korea

Unknown

A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy (TIROX)

Colorectal Neoplasm | Secondary | Gastric Neoplasm

Korea, Republic of
Johns Hopkins University

Recruiting

Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis

Peritoneal Carcinomatosis

United States
Novartis Pharmaceuticals

Active, not recruiting

Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer (KontRASt-02)

Non-Small Cell Lung Cancer

China, Croatia, Taiwan, Greece, Canada, Thailand, Lebanon, Australia, Hong Kong, Slovenia, Spain, Jordan, Romania, Italy, Hungary, India, Turkey, Portugal, Argentina, Malaysia, Korea, Republic of, Colombia, Iceland, Mexico, United States, Chil... and more
Merck Sharp & Dohme LLC

Completed

Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001)

Cancer, Neoplasms, Tumors
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI); Aventis Pharmaceuticals

Terminated

Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus

Esophageal Cancer

United States, Puerto Rico, South Africa
Saladax Biomedical, Inc.
UPMC CancerCenter

Completed

Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients

Prostate Cancer

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix

Cervical Cancer

United States
AmpliMed Corporation

Withdrawn

A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Infinity Pharmaceuticals, Inc.

Completed

Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors

Solid Tumors

United States
Sanofi

Completed

Docetaxel in the Treatment of Hormone Refractory Prostate Cancer

Prostatic Neoplasms

Czech Republic
Jeroen Bosch Ziekenhuis

Unknown

Docetaxel - Carboplatin as Second Line Treatment in Patients With Small Cell Lung Cancer (DOCAR)

Small Cell Lung Cancer

Netherlands
Jina Pharmaceuticals Inc.
Lambda Therapeutic Research Ltd.; Intas Pharmaceuticals, Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

Triple Negative Breast Cancer

United States, India
Genentech, Inc.

Completed

Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors

Neoplasms

United States, Spain, United Kingdom, France
Sun Yat-sen University
Peking University; Zhejiang Cancer Hospital; Xiangya Hospital of Central South... and other collaborators

Not yet recruiting

Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC (NX-NPC)

Nasopharyngeal Carcinoma

China
Uppsala University

Recruiting

Efficacy of Hyperthermic Intraperitoneal Chemotherapy (EFFIPEC)

Colorectal Cancer | Peritoneal Metastases

Sweden
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer

Pancreatic Cancer

China
NCIC Clinical Trials Group

Completed

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Kidney Cancer | Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Bladder Cancer
Samsung Medical Center

Completed

Concomitant Chemoradiotherapy (CCRT) With Weekly Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer

Head and Neck Cancer

Korea, Republic of
Fox Chase Cancer Center
National Cancer Institute (NCI)

Terminated

Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
Carilion Clinic
Sanofi

Terminated

A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation

Advanced Endometrial Adenocarcinoma, Stage III A, B, C

United States
Kyunghee University Medical Center

Unknown

Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer

Solid Tumor
Samsung Medical Center

Completed

Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer

Locally Advanced Stage III or IV Thymic Cancer

Korea, Republic of
Istituto Nazionale per lo Studio e la Cura dei...

Unknown

Docetaxel in Treating Patients With Non-Small Cell Lung Cancer

Lung Cancer

Italy
Scandinavian Prostate Cancer Group

Unknown

Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

Prostate Cancer

Finland, Denmark, Iceland, Norway, Sweden
INSYS Therapeutics Inc

Completed

Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors (LE-DT)

Solid Tumors

United States
Sanofi

Completed

Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax

Lung Neoplasms

Turkey
Yu jiren

Not yet recruiting

Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Adenocarcinoma of the Stomach | Adenocarcinoma of Esophagogastric Junction | Epstein-Barr Virus-Associated Gastric Carcinoma

China
David Bartlett
Sanofi; The Pittsburgh Foundation

Completed

Isolated Liver Perfusion With Oxaliplatin

Unresectable Colorectal Liver Metastases

United States
Tianjin Medical University Cancer Institute and...

Recruiting

Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer

Gastric Cancer

China
Oslo University Hospital

Recruiting

Normothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-OXA)

Colo-rectal Cancer | Peritoneal Metastases

Norway
University of Utah

Terminated

Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer (IPOX-FOLFIRI)

Colorectal Cancer | Peritoneal Carcinoma | Appendiceal Cancer

United States
BeiJing Yijiayi Medicine Techonoloy Co., Ltd.
Dalian Holley Kingkong Pharmaceutical Co., Ltd

Unknown

Clinical Trial of Elemene in Combination With Oxaliplatinin the Treatment of Advanced Primary Liver Cancer

Advanced Primary Liver Cancer

China
National Center for Research Resources (NCRR)
Penn State University

Completed

Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia

Bronchopulmonary Dysplasia
Yu jiren

Recruiting

Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Adenocarcinoma of the Stomach | Mismatch Repair Deficiency | Adenocarcinoma of Esophagogastric Junction

China

Search clinical trials for: docetaxel oxaliplatin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations